VIENNA — Just over half the adults without diabetes who started taking the GLP-1 semaglutide (Wegovy) for weight loss discontinued treatment within a year, with a marked drop-off in younger adults, ...

An OpenAI and Harvard study finds that 24% of ChatGPT use is information-seeking, with non-work usage now exceeding 70%. Seeking information rose to 24% of ChatGPT usage, suggesting overlap with ...

A recent study found that traditional liturgical experiences, including receiving the Eucharist by tongue, indicate a stronger belief among Catholics in the Real Presence. Last year, Natalie A.

For decades, evidence guiding the diagnosis of postpartum haemorrhage has been constrained by traditional aggregate data ...

New research (the Ver-A-T1D trial) presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) (Vienna, 15–19 September) shows that slow-release (SR) verapamil (360mg ...

According to Novo Nordisk, this study was the first to compare these GLP-1 receptor agonists in a real-world setting. Findings from a real-world study evaluating cardiovascular disease-related ...

Large ChatGPT analysis finds global growth, a shrinking gender gap, and everyday tasks like writing and guidance driving most conversations. OpenAI and Harvard economist David Deming today released a ...

The Justice Department quietly removed from its website a study showing far-right extremists were responsible for the bulk of ideologically motivated deaths — a move that comes as the GOP seeks to ...

Lilly's orforglipron shows superior weight loss and blood sugar control Highest dose of the pill leads to 9.2% weight reduction Detailed trial results to be presented at future medical meeting The ...

Compass Inc. agreed to buy Anywhere Real Estate Inc. in a $1.5 billion stock deal that would cement Compass’s status as the largest residential brokerage in the US. Anywhere shares will be exchanged ...

Circulating Tumor DNA Genotyping of Intrinsic and Acquired Gene Alterations in Patients With Advanced Breast Cancer Receiving Palbociclib: Biomarker Results From POLARIS Study FOLFIRINOX (FFX) and ...